News Focus
News Focus
Followers 33
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: None

Monday, 12/22/2014 3:37:34 PM

Monday, December 22, 2014 3:37:34 PM

Post# of 405172
I guess I am 180 degrees out from many on the board today regarding this PR. I think Leo just said Brilacidin may be effective on an indication that traditional antibiotics are ineffective against. "The results are also positive" is a positive not a negative.



"Cellceutix has continued to analyze the data within other populations in the study in addition to the intent-to-treat population. The Company is pleased to report that the results are also positive in the Microbiological Intent-to-Treat population" (MITT

"Biofilm Formation:A Clinically Relevant Microbiological Process"

The most effective strategy for treating these infections may be removal of the biofilm-contaminated device. A better understanding of the process of biofilm formation may impact clinical decision-making by affecting the way blood samples and catheter-tip samples are collected and examined or by providing a clearer picture of the limitations of conventional therapies for treating biofilm-associated infections.

http://cid.oxfordjournals.org/content/33/8/1387.full

LEGEND OF ABBREVIATIONS
B = Brilacidin, the antibiotic
K = Kevetrin, the oncology drug
P = Prurisol, the psoriasis drug
SAE = Serious Adverse Event
IND = Investigational New Drug


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y